Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH 2 -terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 96; no. 17; pp. 9803 - 9808 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Acad Sciences
17-08-1999
National Academy of Sciences The National Academy of Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH 2 -terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of TRAF5 in vivo , we generated TRAF5-deficient mice by gene targeting. Activation of either NF-κB or c-Jun NH 2 -terminal kinase/stress-activated protein kinase by tumor necrosis factor, CD27, and CD40 was not abrogated in traf5 −/− mice. However, traf5 −/− B cells showed defects in proliferation and up-regulation of various surface molecules, including CD23, CD54, CD80, CD86, and Fas in response to CD40 stimulation. Moreover, in vitro Ig production of traf5 −/− B cells stimulated with anti-CD40 plus IL-4 was reduced substantially. CD27-mediated costimulatory signal also was impaired in traf5 −/− T cells. Collectively, these results demonstrate that TRAF5 is involved in CD40- and CD27-mediated signaling. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 To whom reprint requests should be addressed. E-mail: hnakano@med.juntendo.ac.jp. Edited by Elliott D. Kieff, Harvard University, Boston, MA, and approved June 23, 1999 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.96.17.9803 |